TDEs from ascites fluid of melanoma patients delivered Mart1 tumor antigens to DC cells to induce CTL responses for Mart1‐specific clones.128 The consensus from these reports indicates that TDEs can induce effective antitumor immune responses, and that these responses are independent of the MHC type match. The gene discussed is HLA-C; the disease is neoplasm.